CenterHigh
Financial TimesNews report · Jul 21, 4:58 PM
Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads
Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy
← Today's headlines
4 sources checked · Left, Center, and Right included · 15m ago
Different Spin
Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads
Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy
1 Left2 Center1 Right
DIFFERENT SPIN
HOW EACH SIDE WORDED IT
Left-leaningOzempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
The Guardian - BusinessMixed
ozempicmakerrival
Right-leaningNovo Nordisk Sues Eli Lilly, Says Weight-Loss Drug Comparison Ads Are Misleading
The Epoch TimesMixed
lillyweight-lossdrug
Center baseline · 
Financial TimesHighNovo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads
As of July 21, 2026 at 5:32 PM, this is how Optics News reads the wording differences in this story.
What happened Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy.
The headline split The left frames it as "Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads". The right frames it as "Novo Nordisk Sues Eli Lilly, Says Weight-Loss Drug Comparison Ads Are Misleading".
Match confidence Medium confidence. 4 sources across 3 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
4 sources across 3 bias buckets agree on the event.
Framing confidenceStrong
78/99 — headlines create a clearly different first impression.
WHAT EACH SIDE EMPHASIZED
Left / center-leftOzempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
The Guardian - Business · Left · News report
CenterNovo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads
Financial Times · Center · News report
Right / center-rightNovo Nordisk Sues Eli Lilly, Says Weight-Loss Drug Comparison Ads Are Misleading
The Epoch Times · Right · News report
SEE THE HEADLINES
Open source
CenterHigh
Channel NewsAsiaNews report · Jul 21, 5:32 PM
Pharma heavyweights Novo Nordisk Eli Lilly clash over anti-obesity drug ads
Novo Nordisk says Eli Lilly's ads use outdated research and leave out important information, which could mislead consumers.
LeftMixed
The Guardian - BusinessNews report · Jul 21, 5:21 PM
Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
ozempicmakerrivalovermaterially
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli L...
RightMixed
The Epoch TimesNews report · Jul 21, 5:08 PM
Novo Nordisk Sues Eli Lilly, Says Weight-Loss Drug Comparison Ads Are Misleading
lillyweight-lossdrug
The two companies are battling over advertisements comparing their flagship obesity and diabetes medications.
Details78/99 Wording Gap · Medium confidence · 4 sources
78/99 Wording GapMedium confidence4 sources · 3 bias bucketsLive match · 4 sources · 3 buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Jul 21, 4:58 PM: Financial Times joined the source map.
Jul 21, 5:08 PM: The Epoch Times joined the source map.
Jul 21, 5:21 PM: The Guardian - Business joined the source map.
Jul 21, 5:32 PM: Channel NewsAsia joined the source map.
Now: Wording Gap is 78/99 and story health is live match · 4 sources · 3 buckets · comparable news format.